Trial intelligence / Profile preview

Dutch Hamstring Injection Trial Follow-up

NL-OMON42636Withdrawn

Sponsor
Haaglanden Medical Centre
Start
May 2015
Countries
1
01

Overview

Randomised, double-blind trial in Hamstring Injury and hamstring rupture comparing Platelet-rich plasma injection with Placebo injection (2 arms). Primary endpoint: Return to play. Planned start May 2015; status: withdrawn.

02

Drugs

platelet-rich plasma
03

Conditions

Hamstring Injuryhamstring rupture

Beyond the preview

Go deeper on NL-OMON42636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON42636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call